CAMBRIDGE, UK--(BUSINESS WIRE)--Lab21 Limited, the global specialist in personalized medicine and clinical diagnostics, today announces the sale of its laboratory operations based in South Carolina to Reedy Acquisitions Corp, an entity formed by the existing local management and South Carolina based investors. In addition to an immediate cash benefit for Lab21 Ltd, the sale will remove a loss-making business from the Lab21 Group.
